Executive Summary
Dominant $2.95B NASA obligation to Caltech (68% of total) confirms long-term space R&D stability but neutral equity impact as nonprofit. Bullish signals across $1.13B in health/pharma/IT (Elevance $505M, Emergent $422M) and security/IT (Elbit $105M, Pyramid $100M) highlight reliable fed revenue through 2026-2030. HHS contracts total $1.19B (28%), signaling healthcare services momentum amid $4.34B overall obligations with 4 bullish, 3 neutral signals.
Tracking the trend? Catch up on the prior General Federal Contracts digest from March 22, 2026.
Investment Signals(3)
- HHS Health IT/Pharma Revenue Lock-in(HIGH)▲
$927M obligated to Elevance and Emergent through 2027+ with $515M outlayed, plus $263M to nonprofits, underscores steady cash flow in CMS/ASPR programs.
- Security/IT Modernization Commitments(MEDIUM)▲
$205M firm obligations to ElbitAmerica (DHS surveillance) and Pyramid (GSA/HUD IT) start 2026 with options/extensions to 2030/2026, no outlays yet but fully funded base.
- Space R&D Continuity at Scale(HIGH)▲
$2.95B Caltech JPL operations (68% total value) with $2.43B outlayed through 2028 reflects NASA's FFRDC reliance but no direct equity plays.
Risk Flags(3)
- Execution[HIGH RISK]▼
Long tenors (2026-2030) across 6/7 contracts expose to funding cuts/delays; $0 outlay on Elbit/Pyramid delays revenue.
- Market[MEDIUM RISK]▼
Firm-fixed-price terms (Emergent $422M, Elbit $105M) risk cost overruns; award-fee/no-fee limits profits (Elevance, Mount Sinai).
- Regulatory[MEDIUM RISK]▼
Foreign-owned entities (Emergent Canada, ElbitAmerica) in HHS/DHS face scrutiny; 20%+ subawards (Elevance $171M, RTI $23M) add dependency.
Opportunities(3)
- ◆
Unexercised options total ~$350M+ (Caltech $202M, Emergent $284M, Mount Sinai $44M, Elbit/Pyramid minor).
- ◆
Remaining outlays ~$1.3B ($518M Caltech, $246M Elevance, $167M Emergent, $54M RTI).
- ◆
Small biz set-asides like Pyramid $100M position for GSA/HUD follow-ons.
Sector Themes(3)
- ◆
$1.19B (28%) across IT, pharma, R&D signals CMS/ASPR/NIH prioritization.
- ◆
Caltech's $2.95B (68%) locks in JPL ops to 2028.
- ◆
$205M new-ish awards for DHS surveillance/HUD IT start 2026.
Watch List(4)
- 👁
{"entity"=>"Emergent BioSolutions", "reason"=>"$422M obligated with $284M options to 2029 in biopharma preparedness.", "trigger"=>"option exercises or outlay >$300M"}
- 👁
{"entity"=>"ElbitAmerica (Elbit Systems)", "reason"=>"$105M DHS surveillance from 2026 with foreign-ownership risks.", "trigger"=>"first outlays or extension to 2030"}
- 👁
{"entity"=>"Pyramid Systems", "reason"=>"$100M small biz IT BPA with near-term 2026 end.", "trigger"=>"extension to Sep 2026 or new GSA calls"}
- 👁
{"entity"=>"Elevance Health (National Govt Services)", "reason"=>"$505M CMS IT steady outlays through 2027.", "trigger"=>"subaward flow or award fee adjustments"}
Get daily alerts with 3 investment signals, 3 risk alerts, 3 opportunities and full AI analysis of all 7 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
All NASA Contracts — March 24, 2026
All NASA Contracts
March 24, 2026
S&P 500 Technology Sector SEC Filings — March 24, 2026
S&P 500 Technology Sector SEC Filings
March 24, 2026
Nasdaq 100 Stocks SEC Filings — March 24, 2026
Nasdaq 100 Stocks SEC Filings